Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates
Author:
Funder
Takeda Pharmaceuticals USA Inc Lexington
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference21 articles.
1. IGF-1 as a drug for preterm infants: a step-wise clinical development;Hellstrom;Curr Pharm Des,2017
2. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth;Hellstrom;Pediatrics,2003
3. Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: evaluation of feasibility in a phase II study;Hansen-Pupp;Growth Horm IGF Res,2017
4. rhIGF-1/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial;Ley;J Pediatr,2019
5. Compatibility of drug infusions in the NICU;Kalikstad;Arch Dis Child,2010
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications;World Journal of Pediatrics;2022-11-07
2. A cleavable self-aggregating tag scheme for the expression and purification of disulfide bonded proteins and peptides;Chemical Engineering Science;2022-11
3. The History of the Insulin-Like Growth Factor System;Hormone Research in Paediatrics;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3